BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · IEX Real-Time Price · USD
-0.45 (-2.33%)
At close: May 26, 2023, 4:00 PM
+0.43 (2.28%)
After-hours: May 26, 2023, 6:46 PM EDT

Total Valuation

BTAI has a market cap or net worth of $550.24 million. The enterprise value is $480.49 million.

Market Cap 550.24M
Enterprise Value 480.49M

Important Dates

The last earnings date was Monday, May 8, 2023, before market open.

Earnings Date May 8, 2023
Ex-Dividend Date n/a

Share Statistics

BTAI has 29.16 million shares outstanding. The number of shares has increased by 2.27% in one year.

Shares Outstanding 29.16M
Shares Change (YoY) +2.27%
Shares Change (QoQ) +1.95%
Owned by Insiders (%) 31.26%
Owned by Institutions (%) 53.56%
Float 18.24M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 947.06
Forward PS 9.60
PB Ratio 10.38
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 827.00
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.16, with a Debt / Equity ratio of 1.81.

Current Ratio 6.16
Quick Ratio 5.77
Debt / Equity 1.81
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -177.70% and return on invested capital (ROIC) is -239.20%.

Return on Equity (ROE) -177.70%
Return on Assets (ROA) -85.10%
Return on Capital (ROIC) -239.20%
Revenue Per Employee $3,175
Profits Per Employee -$1.02M
Employee Count 183
Asset Turnover 0.00
Inventory Turnover 0.02


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +63.52% in the last 52 weeks. The beta is 1.11, so BTAI's price volatility has been higher than the market average.

Beta (1Y) 1.11
52-Week Price Change +63.52%
50-Day Moving Average 21.46
200-Day Moving Average 19.82
Average Volume (30 Days) 560,215

Short Selling Information

The latest short interest is 3.35 million, so 11.47% of the outstanding shares have been sold short.

Short Interest 3.35M
Short Previous Month 3.54M
Short % of Shares Out 11.47%
Short % of Float 18.35%
Short Ratio (days to cover) 7.50

Income Statement

In the last 12 months, BTAI had revenue of $581,000 and -$187.08 million in losses. Loss per share was -$6.64.

Revenue 581,000
Gross Profit 552,000
Operating Income -179.37M
Pretax Income -187.08M
Net Income -187.08M
EBITDA -174.96M
EBIT -175.29M
Loss Per Share -$6.64
Full Income Statement

Balance Sheet

The company has $165.52 million in cash and $95.77 million in debt, giving a net cash position of $69.76 million or $2.39 per share.

Cash & Cash Equivalents 165.52M
Total Debt 95.77M
Net Cash 69.76M
Net Cash Per Share $2.39
Equity / Book Value 53.01M
Book Value Per Share 1.82
Working Capital 148.51M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$155.28 million and capital expenditures -$19,000, giving a free cash flow of -$155.30 million.

Operating Cash Flow -155.28M
Capital Expenditures -19,000
Free Cash Flow -155.30M
FCF Per Share -$5.43
Full Cash Flow Statement


Gross margin is 95.01%, with operating and profit margins of -30,872.63% and -32,199.48%.

Gross Margin 95.01%
Operating Margin -30,872.63%
Pretax Margin -32,199.48%
Profit Margin -32,199.48%
EBITDA Margin -30,113.08%
EBIT Margin -30,169.88%
FCF Margin -26,729.78%

Dividends & Yields

BTAI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -34.00%
FCF Yield -28.22%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -2.27%
Shareholder Yield -2.27%
Dividend Details

Analyst Forecast

The average price target for BTAI is $45.83, which is 142.87% higher than the current price. The consensus rating is "Strong Buy".

Price Target $45.83
Price Target Difference 142.87%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (5Y) 329.26%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a